Upgrade to SI Premium - Free Trial

Celldex Therapeutics (CLDX) PT Raised to $57 at Morgan Stanley

September 23, 2026 6:19 AM
(Updated - September 23, 2026 6:20 AM EDT)

Morgan Stanley analyst Judah Frommer raised the price target on Celldex ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change